In the presence of a selective ERK1/2 inhibitor, FR180204, we observed a dose-dependent reduction at the transcript levels of Snail/Twist1 in oral cancer cells (Figure 4C). The gene discussed is SNAI1; the disease is lip and oral cavity carcinoma.